GlassScriptPhysician profile
David Lawrence Phillips
NPI 1871546283
$11,781.34
in general payments reported to CMS, 2019-2025
53 companies · $916 in 2025
The $916 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,616 · 2020: $2,856 · 2021: $1,496 · 2022: $1,733 · 2023: $1,786 · 2024: $1,378 · 2025: $916.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,946 · Education: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,946.40 |
| Education | $134.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $2,263.29 | 2019-2024 | Provenge |
| Janssen Biotech, INC. | $1,670.51 | 2019-2025 | Erleada, Akeega, Balversa |
| Pfizer INC. | $1,343.68 | 2019-2025 | |
| Abbvie INC. | $1,269.19 | 2019-2025 | |
| Astellas Pharma US INC | $922.83 | 2019-2024 | Xtandi, Myrbetriq |
| Boston Scientific Corporation | $408.39 | 2019-2024 | Tactra, Ams 700 |
| Bayer Healthcare Pharmaceuticals INC. | $295.77 | 2019-2025 | |
| Blue Earth Diagnostics | $290.68 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $247.72 | 2023-2025 | Orgovyx, Gemtesa |
| Endo Pharmaceuticals INC. | $247.54 | 2019-2023 | Aveed, Xiaflex |
| Merck Sharp & Dohme LLC | $229.19 | 2020-2025 | Lynparza, Keytruda, Welireg |
| Olympus America INC. | $220.38 | 2023-2025 | Itind System |
| Amgen INC. | $194.73 | 2019-2022 | |
| Janssen Scientific Affairs, LLC | $150.00 | 2023 | |
| Foundation Medicine, INC. | $149.65 | 2020-2022 |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.